The role of heat-not-burn, snus and other nicotine-containing products as interventions for epileptic patients who take phenytoin and smoke cigarettes
Background: Cigarette smoke increases the metabolism of phenytoin, a widely used anti-epileptic agent, by inducing cytochrome P450 enzymes in the liver. Therefore, cigarette smoke may reduce the clinical effect of phenytoin. Switching from cigarettes to smoke-free products (e.g., heat-not-burn, snus...
Main Author: | P.N. Valodia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Toxicology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214750022000774 |
Similar Items
-
Introducing a Novel Biorelevant In Vitro Dissolution Method for the Assessment of Nicotine Release from Oral Tobacco-Derived Nicotine (OTDN) and Snus Products
by: Matthias M. Knopp, et al.
Published: (2022-02-01) -
Smoking and snus use in youth: risk factors and socio-economic profile
by: Ingeborg Lund, et al.
Published: (2023-04-01) -
Self-assembled core-shell nanoparticles with embedded internal standards for SERS quantitative detection and identification of nicotine released from snus products
by: Yongfeng Tian, et al.
Published: (2024-03-01) -
Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study
by: Pesola Francesca, et al.
Published: (2023-09-01) -
Use of tobacco, nicotine and cannabis products among students in Switzerland
by: Jana Affolter, et al.
Published: (2023-03-01)